Organization Overview
Historical Acquisition Tree
Alternative names
Key: UCB (26) Acquired (8)
acetaminophen (tylenol) (1982)
alprazolam (2005)
amphetamine (Adderall) (1955)
baclofen (lioresal) (2003)
bimekizumab (Bimzelx) (2023 NDA)
brivaracetam (briviact) (2016 NDA)
carbidopa (sinemet) (2004)
certolizumab pegol (cimzia) (2008 NDA)
chlorpheniramine (ChlorTrimeton) (1984 NDA)
dexamethasone (1962)
dextroamphetamine (Dexedrine) (1955 NDA)
diethylpropion hydrochloride (tenuate)
famotidine (pepcid) (2004)
fenfluramine (Pondimin) (2020)
hydrochlorothiazide (esidrix) (1997)
hydrocodone (hycodan) (1987)
lacosamide (vimpat) (2008 NDA)
levetiracetam (keppra) (1999 NDA)
levocetirizine (xyzal) (2007 NDA)
levodopa (larodopa) (2004)
midazolam (versed) (2019)
moexipril (univasc) (1995)
phentermine (wyamine) (1959)
phenylpropanolamine (Propadrine) (1984 NDA)
pseudoephedrine (Benylin) (1987)
rotigotine (neupro) (2007)
rozanolixizumab (RYSTIGGO) (2023 NDA)
theophylline (synophylate) (1985)
urea (1962)
zilucoplan (ZILBRYSQ) (2023 NDA)
Key: UCB (0) Acquired (5)
Key: UCB (12) Acquired (7)
adalimumab (humira) (4 trials)
bimekizumab (Bimzelx) (30 trials)
dapirolizumab pegol (2 trials)
ferrous glycine sulphate complex (1 trial)
hydrocodone (hycodan) (8 trials)
Key: UCB (6) Acquired (6)
Key: UCB (10) Acquired (3)
Alzheimer Disease (Phase 2)
Arthritis (Phase 3)
Arthritis, Psoriatic (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Crohn Disease (Phase 3)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Drug Resistant Epilepsy (Phase 3)
Eczema (Phase 2)
Epilepsy (Phase 3)
Epilepsy, Absence (Phase 3)
Epilepsy, Reflex (Phase 3)
Hidradenitis (Phase 3)
Hidradenitis Suppurativa (Phase 3)
Lupus Erythematosus, Systemic (Phase 3)
Muscle Weakness (Phase 3)
Myasthenia Gravis (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2)
Paralysis (Phase 1)
Parkinson Disease (Phase 2)
Polyradiculoneuropathy (Phase 2)
Psoriasis (Phase 3)
Psychomotor Agitation (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Respiratory Insufficiency (Phase 2)
Restless Legs Syndrome (Phase 3)
Seizures (Phase 3)
Spondylarthritis (Phase 3)
Spondylitis (Phase 3)
Spondylitis, Ankylosing (Phase 3)
Supranuclear Palsy, Progressive (Phase 1)
Syndrome (Phase 3)
Thrombocytopenia (Phase 3)
Urticaria (Phase 1)
Wounds and Injuries (Phase 2)